Abbott to buy Cardiovascular Systems, Inc. for $890M

Abbott Laboratories announced it will acquire Cardiovascular Systems, Inc. (CSI) for $890 million Thursday morning.

CSI is a medical device company based in St. Paul, Minnesota that manufactures products for atherectomy, a minimally-invasive heart procedure. The company also has an early-stage pipeline of complementary vascular intervention devices in its pipeline.